Pontifax (Israel) IV, L.P. (CIK 1726039) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-17). Recent activity: Sell KROS (2.3M shares), Sell KROS (1.1M shares), Sell KROS (1.2M shares), Sell KROS (155,262 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-17 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 2.3M | $40.6M |
| 2025-10-17 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 1.1M | $19.9M |
| 2025-10-17 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 1.2M | $21.8M |
| 2025-10-17 | Keros Therapeutics, Inc. (KROS) | 10% Owner | Sell | 155,262 | $2.8M |
来源：SEC Form 4 申报文件 · 截至 2025-10-17